Growth Metrics

Fulgent Genetics (FLGT) Depreciation and Depletion (2017 - 2026)

Fulgent Genetics' Depreciation and Depletion history spans 10 years, with the latest figure at $3.9 million for Q1 2026.

  • On a quarterly basis, Depreciation and Depletion rose 2.63% to $3.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $15.7 million, a 0.64% increase, with the full-year FY2025 number at $15.7 million, down 4.27% from a year prior.
  • Depreciation and Depletion hit $3.9 million in Q1 2026 for Fulgent Genetics, down from $4.0 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for FLGT hit a ceiling of $7.6 million in Q3 2022 and a floor of $3.7 million in Q1 2022.
  • Historically, Depreciation and Depletion has averaged $4.6 million across 5 years, with a median of $4.0 million in 2024.
  • Biggest five-year swings in Depreciation and Depletion: soared 204.0% in 2022 and later tumbled 43.42% in 2023.
  • Tracing FLGT's Depreciation and Depletion over 5 years: stood at $7.6 million in 2022, then plummeted by 42.11% to $4.4 million in 2023, then fell by 9.09% to $4.0 million in 2024, then rose by 0.0% to $4.0 million in 2025, then fell by 2.5% to $3.9 million in 2026.
  • Business Quant data shows Depreciation and Depletion for FLGT at $3.9 million in Q1 2026, $4.0 million in Q4 2025, and $3.9 million in Q3 2025.